MICRONIT BV

Their core work

Micronit is a Dutch SME specializing in the design and manufacture of microfluidic chips and micro/nano-fabricated devices. Based in Enschede — a European hub for microtechnology near the University of Twente — they supply precision glass and polymer microfluidic components to research consortia and industry. Their role across H2020 projects consistently involves fabricating, testing, and scaling up microfluidic devices for applications ranging from biopharmaceutical process monitoring to medical diagnostics and nano-enabled membranes.

What they specialise in

How they've shifted over time

In their earlier H2020 projects (2018–2019), Micronit contributed microfluidic components to fundamental science and analytical applications — biopharmaceutical process monitoring (iConsensus), synthetic biology compartmentalisation (CLASSY), and biomarker detection (TO_AITION). From 2020 onward, their focus shifted decisively toward manufacturing scale-up and industrialization: nano-enabled surfaces, roll-to-roll production, polymer micro/nano processing, device validation, quality management, and regulatory readiness. This evolution tracks a company moving from supplying research-grade prototypes to positioning itself as a production-scale microfluidics manufacturer.

Micronit is transitioning from a research-grade microfluidics supplier toward production-scale manufacturing of polymer and nano-enabled microdevices, with growing emphasis on medical device regulation and quality management.

How they like to work

Micronit operates exclusively as a specialist participant — they have never coordinated an H2020 project, instead contributing their fabrication expertise to consortia led by others. With 152 unique partners across 21 countries in just 8 projects, they work in large, diverse consortia and appear comfortable integrating into complex multi-partner environments. This pattern suggests a reliable technology provider that research groups and companies can plug into their consortium to handle the microfluidics hardware layer.

Across 8 projects, Micronit has collaborated with 152 unique partners in 21 countries, giving them one of the broader networks you'd expect from an SME of this size. Their base in Enschede (Netherlands) places them at the heart of European microtechnology, with connections spanning Western and Southern Europe.

What sets them apart

Micronit occupies a specific and valuable niche: they are one of few European SMEs that can both prototype and scale up microfluidic devices, bridging the gap between lab-grade chips and industrially manufactured products. Their keyword trajectory — from analytical sensing to roll-to-roll production, device validation, and regulation — signals a company that understands the full path from research to market. For consortium builders, they offer a rare combination: hands-on microfabrication capability with real experience navigating the scale-up challenges that kill most microfluidics innovations.

Highlights from their portfolio

• NextGenMicrofluidics
  Their largest funded project (EUR 773K) and the clearest expression of their core mission: building a test bed for upscaling nano-enabled microfluidic devices to roll-to-roll production.
• SIMPPER_MedDev
  A Marie Skłodowska-Curie training network focused on polymer micro/nano processing for medical devices — positions Micronit at the intersection of manufacturing science and medical regulation.
• iConsensus
  Their earliest H2020 project, demonstrating their roots in precision analytical microfluidics for biopharmaceutical quality control.